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Movie: A time-lapse deconvolution microscopy study of polyamide 1-bodipy localizing 
to the nucleus of MT2 cells is shown.  Cells were first stained with MitoTracker as a 
cytoplasmic marker and then incubated with 1-bodipy at 2 µM concentration in culture 
medium.  Images were acquired every 2 min for the first 2 h, and then every 30 min for 
the subsequent 10 h. 
 
Figure S1.  DNase I Footprinting Reactions with Polyamide 1 
Reactions contained a singly end-labeled 300 bp PCR fragment comprising the HIV-1 
promoter and enhancer, with the end-label on the bottom strand.  G+A sequencing 
reactions of the same DNA are included as markers.  The footprints generated by 
polyamide 1 are indicated with vertical bars alongside the autoradiogram, at sites A 
and E (as in Figure 1B).  The location of the TATA box is also indicated.  (A) 
Footprinting reactions contained the following concentrations of polyamide: none (lane 
labeled “0”); 1, 2.5, 5, 10, 25, 50, 100, 250, and 500 pM; and 1, 2.5, 5, and 10 nM.  (B) Effect 
of competing genomic DNA on polyamide binding to the radiolabeled PCR fragment.  
Reactions contained 500 ng of genomic DNA isolated from cultured 5.25 CEM cells.  
Polyamide concentrations were: none (lane labeled “0”); 10, 25, 50, 100, 250, and 500 
pM; and 1, 2.5, 5, 10, 25, 50, and 100 nM.  (C) Quantitative analysis of DNase I 
footprinting data.  The fraction of the radiolabeled DNA bound by polyamide 1 at site A 
adjacent to the TATA box (from the gels shown in panels A and B and other data not 
shown) was obtained by phosphorimage analysis and is plotted versus polyamide 
concentration.  The phosphorimager signal (for each lane) within the footprint was 
normalized to a band outside of the footprint that did not change in intensity 
throughout the titration.  Circles correspond to reactions without competing DNA; 
diamonds and squares correspond to reactions containing 250 ng or 500 ng competitor 
genomic DNA per reaction, respectively.  The lines are the best-fit Langmuir binding 
titration isotherms with a Hill coefficient fixed at n = 1.  50% binding for each of these 
data sets is observed at polyamide concentrations of 65 (± 9) pM, 1.0 (± 0.15) nM, and 2.5 
(± 0.14) nM, respectively, with estimated errors in parentheses. 
 
Figure S2.  Thermal Cleavage Assay for DNA Alkylation by Polyamide 1-CHL 
(A) Reactions contained ~3 fmol of labeled PCR product (labeled on the bottom strand), 
incubated in the absence (no competitor, lanes 2-9) or presence of 250 ng of genomic 
DNA (lanes 10-14) in a total volume of 100 µL for 22 h at 37°C, prior to thermal cleavage 
and gel analysis, with the following concentrations of 1-CHL: no polyamide, lane 2; 100 
and 300 pM, lanes 3 and 4, respectively; and 1, 3, 10, 30, and 100 nM, lanes 5-9 and 10-
14, respectively.  A G+A sequencing reaction of the same DNA is shown (lane 1).  The 
position of the TATA box is indicated, along with polyamide binding sites, indicated A, 
B, C, E.  Site B, described by Wurtz and Dervan [13], is a single nucleotide mismatch in 
the HXB2 isolate, due to G -> C change at nucleotide position 421 (Figure 1B).  Note that 
no alkylation is observed at site D on the bottom strand.  Nucleotide positions of the 
major alkylation sites are given relative to the 5’ end of the LTR in the HXB2 isolate.  (B) 
The DNA sequences encompassing each of the polyamide binding sites A-E in the HIV-
1 LTR of strain HXB2 are shown, along with the sites of alkylation mapped by thermal 
cleavage, indicated with vertical arrows and nucleotide positions.  Data are from panel 
A for the bottom strand and experiments not shown for the top strand.  Note that this 
polyamide can bind its target site in two orientations due to the symmetrical nature of 
the recognition sequence 5’-WGCWGCW-3’, resulting in alkylation on both sides of the 
binding-site.  Models are as in Figure 1A, with CHL denoted with a hexagon; 
mismatches are boxed.  Mismatch sites C and D differ from those observed previously 
[13] due to differences in HIV-1 LTR sequences studied. 
 
